Safranal-Standardized Saffron Extract Improves Metabolic, Cognitive, and Anxiolytic Outcomes in Aged Mice via Hypothalamic–Amygdalar Peptide Modulation

<i>Background</i>: Population aging increases susceptibility to cognitive decline, anxiety, and metabolic dysregulation, yet safe and effective interventions remain limited. Saffron (<i>Crocus sativus</i> L.) has been traditionally used to enhance mood and cognition, and its main metabolites, crocins and safranal, exert neuroprotective, anxiolytic, and metabolic effects. However, variability in extract composition and frequent adulteration hinder reproducibility. <i>Objectives</i>: To clarify the efficacy of genuine saffron preparations in aging, we investigated a saffron extract standardized for safranal and crocin content (SSE). <i>Methods</i>: Safranal bioavailability was first characterized in rats, followed by an evaluation of behavioral, neuroendocrine, and metabolic outcomes after 35 days of oral SSE administration (25 or 200 mg/kg/day) in 25-month-old male C57BL/6 mice. Behavioral performance was assessed using open field and novel object recognition tests, while molecular analyses targeted neuropeptides in the hypothalamus and amygdala, hippocampal plasticity markers, cortical inflammatory proteins, and hepatic lipid metabolism genes. <i>Results</i>: SSE administration induced a rapid but transient increase in the plasma's safranal, confirming its bioavailability. In aged mice, the low dose prevented age-related weight loss and modulated hepatic lipid metabolism, whereas the high dose reduced anxiety-like behavior and improved recognition memory. The anxiolytic effects are consistent with elevated hypothalamic <i>Npy</i>, an anxiolytic peptide, reduced amygdalar <i>Crh</i>, a key mediator of stress and anxiety, and decreased hypothalamic <i>Hcrt,</i> an arousal modulator. The improvement in memory is associated with modulation of the cortical and hippocampal inflammatory and endocannabinoid proteins involved in neural plasticity. <i>Conclusions</i>: These findings highlight content-standardized saffron extracts as a promising multi-target nutraceuticals for healthy aging.

Authors

Institutions

Publication Details

Journal
Nutrients
Published
2026-01-16
DOI
https://doi.org/10.3390/nu18020291
Primary Topic
Saffron Plant Research Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Safranal-Standardized Saffron Extract Improves Metabolic, Cognitive, and Anxiolytic Outcomes in Aged Mice via Hypothalamic–Amygdalar Peptide Modulation

Carlos Sanjuan, Elena Baixerás, Ana Gavito, A. Villar et al.
Nutrients
Saffron Plant Research Studies
article

Safranal-Standardized Saffron Extract Improves Metabolic, Cognitive, and Anxiolytic Outcomes in Aged Mice via Hypothalamic–Amygdalar Peptide Modulation

Carlos Sanjuan, Elena Baixerás, Ana Gavito, A. Villar, Juan Antonio Navarro, Antonia Serrano, Fernando Rodríguez de Fonseca, Yolanda Alfonso, Alonso Rodríguez-Martín, Sonia Rivas, Juan Decara
article en

Abstract

<i>Background</i>: Population aging increases susceptibility to cognitive decline, anxiety, and metabolic dysregulation, yet safe and effective interventions remain limited. Saffron (<i>Crocus sativus</i> L.) has been traditionally used to enhance mood and cognition, and its main metabolites, crocins and safranal, exert neuroprotective, anxiolytic, and metabolic effects. However, variability in extract composition and frequent adulteration hinder reproducibility. <i>Objectives</i>: To clarify the efficacy of genuine saffron preparations in aging, we investigated a saffron extract standardized for safranal and crocin content (SSE). <i>Methods</i>: Safranal bioavailability was first characterized in rats, followed by an evaluation of behavioral, neuroendocrine, and metabolic outcomes after 35 days of oral SSE administration (25 or 200 mg/kg/day) in 25-month-old male C57BL/6 mice. Behavioral performance was assessed using open field and novel object recognition tests, while molecular analyses targeted neuropeptides in the hypothalamus and amygdala, hippocampal plasticity markers, cortical inflammatory proteins, and hepatic lipid metabolism genes. <i>Results</i>: SSE administration induced a rapid but transient increase in the plasma's safranal, confirming its bioavailability. In aged mice, the low dose prevented age-related weight loss and modulated hepatic lipid metabolism, whereas the high dose reduced anxiety-like behavior and improved recognition memory. The anxiolytic effects are consistent with elevated hypothalamic <i>Npy</i>, an anxiolytic peptide, reduced amygdalar <i>Crh</i>, a key mediator of stress and anxiety, and decreased hypothalamic <i>Hcrt,</i> an arousal modulator. The improvement in memory is associated with modulation of the cortical and hippocampal inflammatory and endocannabinoid proteins involved in neural plasticity. <i>Conclusions</i>: These findings highlight content-standardized saffron extracts as a promising multi-target nutraceuticals for healthy aging.

NutrientsVol. 18(2)
Andalusian Centre for Nanomedicine and Biotechnology (ES), Instituto de Investigación Biomédica de Málaga (ES), Universidad de Málaga (ES)
Openalex Percentile: Top 86%
Saffron Plant Research Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.